ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,136Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 978

$758K Total Retail Price of All Prescriptions

Rank: 13 out of 978

482 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 14,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 1,093 855 1 2
LISINOPRIL 898 646 2 1
WARFARIN SODIUM 678 673 3 11
OMEPRAZOLE 669 439 4 3
FUROSEMIDE 594 538 5 9
LEVOTHYROXINE SODIUM 541 405 6 4
HYDROCHLOROTHIAZIDE 466 417 7 5
METOPROLOL TARTRATE 413 379 8 10
AMLODIPINE BESYLATE 359 280 9 6
ALENDRONATE SODIUM 295 220 10 20
CITALOPRAM HBR 286 267 11 14
ATENOLOL 272 237 12 8
METFORMIN HCL 259 230 13 7
ATORVASTATIN CALCIUM 241 194 14 12
TRAZODONE HCL 210 155 15 18
ALLOPURINOL 205 205 16 34
HYDROCODONE-ACETAMINOPHEN 194 143 S3 17 17
SERTRALINE HCL 188 161 18 21
DONEPEZIL HCL 178 178 19 26
GLYBURIDE 166 164 R 20 44
ZOLPIDEM TARTRATE 162 138 21 32
PANTOPRAZOLE SODIUM 162 139 21 39
TAMSULOSIN HCL 159 100 23 33
BISOPROLOL-HYDROCHLOROTHIAZIDE 158 110 24 148
PRAVASTATIN SODIUM 154 122 25 16
LOVASTATIN 153 142 26 29
MIRTAZAPINE 151 151 27 31
TRAMADOL HCL 144 116 28 24
CARVEDILOL 121 102 29 55
NAMENDA 118 118 30 45
OXYCODONE-ACETAMINOPHEN 109 72 S2 31 25
POTASSIUM CHLORIDE 109 102 31 41
LIPITOR 108 82 33 84
VERAPAMIL ER 95 83 34 88
METFORMIN HCL ER 93 76 35 48
IPRATROPIUM-ALBUTEROL 90 90 36 101
EVISTA 88 88 37 130
DIGOXIN 87 75 38 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 50 39 36
LOSARTAN POTASSIUM 85 83 39 22
FLUTICASONE PROPIONATE 85 38 39 28
QUINAPRIL HCL 84 82 42 95
GABAPENTIN 84 75 42 15
PAROXETINE HCL 83 57 44 52
QUETIAPINE FUMARATE 82 65 45 51
RANITIDINE HCL 82 77 45 27
CLOPIDOGREL 80 61 47 61
CIPROFLOXACIN HCL 77 72 48 105
IBUPROFEN 76 57 49 38
CLOTRIMAZOLE-BETAMETHASONE 75 62 50 165
ZETIA 75 65 50 109
CARBIDOPA-LEVODOPA 74 74 52 81
PROAIR HFA 72 50 53 19
FENTANYL 72 72 S2 53 85
COMBIVENT 71 57 55 110
POLYETHYLENE GLYCOL 3350 67 40 56 58
JANUVIA 67 67 56 82
PHENYTOIN SODIUM EXTENDED 67 42 56 147
NOVOLOG 66 65 59 121
ETODOLAC 66 46 59 161
NITROGLYCERIN PATCH 66 66 59 151
DILTIAZEM 24HR CD 64 64 62 111
FLUOXETINE HCL 64 38 62 42
CRESTOR 64 64 62 30
AGGRENOX 63 63 65 257
DOXAZOSIN MESYLATE 62 62 66 90
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 47 67 133
SPIRIVA 57 57 67 37
TRIAMCINOLONE ACETONIDE 57 47 67 136
ENALAPRIL MALEATE 56 53 70 64
FINASTERIDE 56 43 70 72
FLOVENT HFA 54 54 72 91
NIFEDIPINE ER 54 54 72 70
FENOFIBRATE 53 18 74 53
OXYBUTYNIN CHLORIDE ER 52 52 75 99
BUSPIRONE HCL 52 31 75 187
LEVEMIR 52 52 75 176
AMOXICILLIN 51 24 78 178
METOPROLOL SUCCINATE 50 50 79 13
DETROL LA 50 47 79 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.